NCT04730869View on ClinicalTrials.gov

Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma

NAActive, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

February 18, 2025

Study Completion Date

June 26, 2026

Conditions
Glioblastoma
Interventions
OTHER

Standard Treatment Plus Metabolic Therapy Program

"See description under Arms."

Trial Locations (1)

3204

Waikato Hospital, Hamilton

All Listed Sponsors
collaborator

Wellington Hospital

OTHER_GOV

lead

Waikato Hospital

OTHER